Concerns they concluded that augmentation of SSRIs with lithium or an atypical antipsychotic drug is likely to be beneficial in patients with treatment-resistant depression, and that there was no statistically significant difference between the 2 augmentation strategies.
depresia rezistenta
Concerns they concluded that augmentation of SSRIs with lithium or an atypical antipsychotic drug is likely to be beneficial in patients with treatment-resistant depression, and that there was no statistically significant difference between the 2 augmentation strategies.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment